Zepto Won Top Prize in the RESI Boston 2019 Innovation Challenge

Zepto Life Technology, an innovative in-vitro diagnostics development company, is proud to feature its advanced “lab-on-a-chip” technology, which uses Giant Magneto Resistance (GMR) for target sensing. At the RESI conference, Zepto demonstrated the impressive detection capabilities of its GMR platform with examples from both immunoassay and molecular targets.

Highlighted applications included detecting cancer gene mutations such as PIK3CA, EGFR, and KRAS, as well as cardiac-related targets like Troponin immunoassays. These demonstrations highlight the versatility and advanced functionality of Zepto’s GMR technology in providing precise and reliable diagnostic solutions.

 

About RESI

The Redefining Early-Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain, connecting start-ups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health (4 Ds). RESI caters to both the earliest stage start-ups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding. RESI is a unique and powerful tool for sourcing assets and advancing innovation across early-stage life science and healthcare.

https://resiconference.com/past-resi-program-guide/

 

About Zepto Life Technology

Founded in 2014, Zepto Life Technology is a privately held company based in St. Paul, Minnesota. We are at the forefront of developing groundbreaking products that can detect invasive fungal infections using cell-free DNA found in blood. Our cutting-edge detection technology, Giant Magneto Resistance (GMR), is renowned for its high sensitivity and specificity. This Nobel Prize-winning technology from 2007 enables us to detect multiple infections accurately without compromising specificity.

In collaboration with Mayo Clinic, Zepto Life Technology is committed to advancing healthcare by providing precise and reliable diagnostic solutions.